These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15371919)

  • 41. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.
    Nardone G; Staibano S; Rocco A; Mezza E; D'armiento FP; Insabato L; Coppola A; Salvatore G; Lucariello A; Figura N; De Rosa G; Budillon G
    Gut; 1999 Jun; 44(6):789-99. PubMed ID: 10323879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.
    Sung JJ; Lin SR; Ching JY; Zhou LY; To KF; Wang RT; Leung WK; Ng EK; Lau JY; Lee YT; Yeung CK; Chao W; Chung SC
    Gastroenterology; 2000 Jul; 119(1):7-14. PubMed ID: 10889149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
    Urakami Y; Sano T
    J Med Invest; 2003 Feb; 50(1-2):48-54. PubMed ID: 12630568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.
    Fu S; Ramanujam KS; Wong A; Fantry GT; Drachenberg CB; James SP; Meltzer SJ; Wilson KT
    Gastroenterology; 1999 Jun; 116(6):1319-29. PubMed ID: 10348815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification.
    Kodaka Y; Futagami S; Tatsuguchi A; Yamawaki H; Sato H; Hashimoto S; Kawagoe T; Ueki N; Nagoya H; Maruki Y; Miyake K; Gudis K; Sakamoto C; Iwakiri K
    Digestion; 2017; 96(3):173-183. PubMed ID: 28946145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of cyclooxygenase-2 in Helicobacter pylori- induced gastritis in Mongolian gerbils.
    Takahashi S; Fujita T; Yamamoto A
    Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G791-8. PubMed ID: 11005767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Helicobacter pylori infection on gastric juice pH.
    Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
    Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa.
    Sawaoka H; Kawano S; Tsuji S; Tsuji M; Sun W; Gunawan ES; Hori M
    Prostaglandins Leukot Essent Fatty Acids; 1998 Nov; 59(5):313-6. PubMed ID: 9888205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [COX-2 expression in the H. pylori infected gastric mucosal epithelia and its significance].
    Ding XY; Li DG; Lu HM
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):232-4. PubMed ID: 15949425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
    Mazzoleni LE; Sander GB; Ott EA; Barros SG; Francesconi CF; Polanczyk CA; Wortmann AC; Theil AL; Fritscher LG; Rivero LF; Cartell A; Edelweiss MI; Uchôa DM; Prolla JC
    Dig Dis Sci; 2006 Jan; 51(1):89-98. PubMed ID: 16416218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.
    Cahill RJ; Xia H; Kilgallen C; Beattie S; Hamilton H; O'Morain C
    Dig Dis Sci; 1995 Aug; 40(8):1627-31. PubMed ID: 7648960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype--a link to gastric carcinogenesis.
    Venerito M; Kuester D; Wex T; Roessner A; Malfertheiner P; Treiber G
    Cancer Lett; 2008 Nov; 270(2):218-28. PubMed ID: 18571838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
    Suzuki H; Mori M; Sakaguchi AA; Suzuki M; Miura S; Ishii H
    J Gastroenterol Hepatol; 1998 May; 13(5):516-20. PubMed ID: 9641651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.
    Kodama M; Murakami K; Okimoto T; Abe H; Sato R; Ogawa R; Mizukami K; Shiota S; Nakagawa Y; Soma W; Arita T; Fujioka T
    Scand J Gastroenterol; 2013 Nov; 48(11):1249-56. PubMed ID: 24079881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.